DOI: 10.36347/sjams.2020.v08i04.015

Pages: 1122-1125

Objective: In this study our main goal is to evaluate the importance of biopsy and FNAC as a diagnostic tool in cervical lymphadenopathy cases. Method: This cross-sectional analytical study was done Total 260 patients with cervical lymphadenopathy, persisting for >2 weeks either localized or generalized attending inpatient and outpatient department (particularly surgical, medical, pediatrics, ENT, dermatology) of Dhaka Medical College Hospital, from June 2014 to July 2015. Results: The peak age incidence of cervical lymphadenopathy was observed between 2nd and 3rd decade of life (25.4% in 10 – 20 years and 25% in 20 – 30 years). Another peak was found in 50 years or above. The median age was 28 years and the lowest and highest ages were 5 and 66 years respectively.54% of patients were diagnosed clinically as having tubercular lymphadenitis, 27.7% metastatic carcinoma, 12.7% lymphoma and 5.0% non-specific reactive hyperplasia (NSRH). Conclusion: From our result, we can conclude that, diagnosis of lymphadenopathy is a team effort of the physician surgeon and the pathologist. If there is no regression in size or size increases, open biopsy can used for diagnosis in cervical lymphadenopathy cases.